Analyst Upgrades – Amgen (NASDAQ:AMGN) Stock Gets Upgraded By Argus from Hold to Buy

ME Staff
-
0

Analyst Ratings For Amgen (NASDAQ:AMGN)

Today, Amgen (NASDAQ:AMGN) stock received an upgrade by Argus from Hold to Buy with a price target of $220.00.

Some recent analyst ratings include

  • 1/23/2018-Argus Upgrade from a “Hold ” rating to a ” Buy” rating.
  • 1/2/2018-Piper Jaffray Companies Reiterated Rating of Buy.
  • 12/18/2017-Citigroup was Downgraded by analysts at Citigroup from a “Neutral” rating to a “” rating.
  • 12/15/2017-Goldman Sachs Group was Downgraded by analysts at Goldman Sachs Group from a “Conviction-Buy ” rating to a ” Buy” rating.
  • 11/30/2017-Cann Reiterated Rating of Buy.

Dividend information for Amgen (NASDAQ:AMGN)

Amgen (NASDAQ:AMGN) pays an annual dividend of $4.60 with a yield of 2.38% and an average dividend growth of 23.50% based on a 3 Year Average..

Dividend History for Amgen (NASDAQ:AMGN)

  • On 12/12/2017 Amgen announced a quarterly dividend of $1.32 2.98% with an ex dividend date of 2/14/2018 which will be payable on 3/8/2018.
  • On 10/24/2017 Amgen announced a quarterly dividend of $1.15 2.59% with an ex dividend date of 11/16/2017 which will be payable on 12/8/2017.
  • On 7/28/2017 Amgen announced a quarterly dividend of $1.15 2.64% with an ex dividend date of 8/15/2017 which will be payable on 9/8/2017.
  • On 3/7/2017 Amgen announced a quarterly dividend of $1.15 2.59% with an ex dividend date of 5/15/2017 which will be payable on 6/8/2017.
  • On 12/20/2016 Amgen announced a quarterly dividend of $1.15 3.15% with an ex dividend date of 2/13/2017 which will be payable on 3/8/2017.
  • On 10/14/2016 Amgen announced a quarterly dividend of $1.00 2.46% with an ex dividend date of 11/14/2016 which will be payable on 12/8/2016.
  • On 7/22/2016 Amgen announced a quarterly dividend of $1.00 2.4% with an ex dividend date of 8/15/2016 which will be payable on 9/8/2016.

Recent Insider Trading Activity For Amgen (NASDAQ:AMGN)
Amgen (NASDAQ:AMGN) has insider ownership of 0.19% and institutional ownership of 78.48%.

  • On 1/16/2018 Sean E. Harper, EVP, sold 1,525 with an average share price of $185.62 per share and the total transaction amounting to $283,070.50.
  • On 12/12/2017 Sean E Harper, EVP, sold 1,525 with an average share price of $176.83 per share and the total transaction amounting to $269,665.75.
  • On 11/13/2017 Sean E Harper, EVP, sold 1,525 with an average share price of $171.58 per share and the total transaction amounting to $261,659.50.
  • On 11/8/2017 Carbonnel Francois De, Director, sold 4,000 with an average share price of $173.61 per share and the total transaction amounting to $694,440.00.
  • On 10/9/2017 Sean E Harper, EVP, sold 1,525 with an average share price of $185.95 per share and the total transaction amounting to $283,573.75.
  • On 5/24/2017 Cynthia M Patton, SVP, sold 2,922 with an average share price of $154.40 per share and the total transaction amounting to $451,156.80.
  • On 8/2/2016 Annette Louise Such, VP, sold 3,000 with an average share price of $174.59 per share and the total transaction amounting to $523,770.00.

Recent Trading Activity for Amgen (NASDAQ:AMGN)
Shares of Amgen closed the previous trading session at 193.62 up +1.29 0.67% with 192.3000030517578 shares trading hands.